AQR Capital Management
BIOL

AQR Capital Management’s Biolase, Inc. BIOL Stock Holding History

AQR Capital Management’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2
Closed -$63K – 2268
2015
Q1 		$63K Sell
2
-1
-33% -$28.3K ﹤0.01% 2112
2014
Q4 		$95K Hold
3
– – ﹤0.01% 2450
2014
Q3 		$90K Hold
3
– – ﹤0.01% 2456
2014
Q2 		$80K Hold
3
– – ﹤0.01% 2480
2014
Q1 		$102K Hold
3
– – ﹤0.01% 2512
2013
Q4 		$120K Sell
3
-1
-25% -$23.7K ﹤0.01% 2500
2013
Q3 		$84K Buy
4
+2
+100% +$64.4K ﹤0.01% 2436
2013
Q2 		$106K Buy
+2
New +$112K ﹤0.01% 2279

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return

AQR Capital Management's BIOL Position: Q2 2015 in Review

AQR Capital Management sold out of Biolase, Inc. (BIOL) in Q2 2015, closing a stake of 2 shares — an estimated $63K sold.

AQR Capital Management first reported a position in BIOL in Q2 2013 and held it in 8 quarters. The position peaked at $120K in Q4 2013. 34 funds tracked by Wall St. Rank hold BIOL as of Q2 2015.

  • AQR Capital Management reported no remaining Biolase, Inc. position as of Q2 2015 after selling out during the quarter.
  • AQR Capital Management sold 2 Biolase, Inc. shares in Q2 2015, an estimated $63K.
  • AQR Capital Management first reported a position in Biolase, Inc. in Q2 2013 and held it in 8 quarters.
  • AQR Capital Management's Biolase, Inc. position peaked at $120K in Q4 2013.
  • 34 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2015.

Based on AQR Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.